Stock Detail
ALLERGAN INC
Drug Manufacturers Other
AGN @ Yahoo Finance | AGN Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $82.99 | $84.64 | $-0.81 | -0.97% | 0.20 | $83.80 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $82.90 | $82.51 | 1.32M | 25.31B | 2.05M | 28.07 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 85.51 | 84.25 | 83.38 | 82.12 | 81.25 |
Stock Profile
Allergan, Inc. engages in the development and commercialization of pharmaceutical products for the ophthalmic, neurological, dermatological, and other markets. It engages in pharmaceutical research related to disease areas, such as glaucoma, retinal disease, dry eye, psoriasis, acne, and movement disorders. The company also offers aesthetic-related pharmaceuticals and over-the-counter products. Allergan offers prescription and nonprescription products to treat diseases and disorders of the eye, including glaucoma, dry eye, inflammation, infection, and allergy. Its glaucoma treatment products include Alphagan and Alphagan P, a brimonidine tartrate ophthalmic solution; Lumigan, a bimatoprost ophthalmic solution; and Restasis, a cyclosporine ophthalmic emulsion. Its ophthalmic anti-inflammatory products include Acular and Acular LS, as well as Pred Forte, a topical steroid. The company's ophthalmic infection treatment products include Ocuflox, Oflox, Zymar, and Exocin. It offers Alocril and Elestat ophthalmic solutions for the treatment of itch associated with allergic conjunctivitis. The company's neuromodulator product, Botox, is used therapeutically in the treatment of neuromuscular disorders. Allergan's skin care products include Tazorac gel for the treatment of plaque psoriasis; Azelex cream used in the topical treatment of mild to moderate inflammatory acne; Avage, a tazarotene cream indicated for the treatment of facial fine wrinkling, mottled hypo and hyperpigmentation, and benign facial lentigines; Prevagetm, an antioxidant cream, that reduces the appearance of fine lines and wrinkles, as well as provides protection against sun damage, air pollution, and cigarette smoke; and glycolic acid-based products. Allegran, Inc. has a strategic research collaboration agreement with ExonHit Therapeutics to identify new molecular targets based on ExonHits' gene profiling DATAS technology. Allegran was incorporated in 1948 and is headquartered in Irvine, California.